Global Patent Index - EP 3673910 A1

EP 3673910 A1 20200701 - SUGAR CHAIN-RELATED GENE AND USE THEREOF

Title (en)

SUGAR CHAIN-RELATED GENE AND USE THEREOF

Title (de)

MIT ZUCKERKETTE ASSOZIIERTES GEN UND VERWENDUNG DAVON

Title (fr)

GÈNE APPARENTÉ À UNE CHAÎNE DE SUCRE ET SON UTILISATION

Publication

EP 3673910 A1 20200701 (EN)

Application

EP 20151386 A 20081226

Priority

  • JP 2007336518 A 20071227
  • EP 18151424 A 20081226
  • EP 15194114 A 20081226
  • EP 08866254 A 20081226
  • JP 2008004025 W 20081226

Abstract (en)

As a result of dedicated studies, the present inventors succeeded in discovering, for the first time, that fibrogenesis could be suppressed at the physiological tissue level by inhibiting sulfation at position 4 or 6 of GalNAc, which is a sugar that constitutes sugar chains. Furthermore, the present inventors conducted studies using various disease model animals, and as a result, successfully demonstrated that inhibitors of sulfation at position 4 or 6 of GalNAc had therapeutic effects on diseases caused by tissue fibrogenesis (tissue fibrogenic disorders).

IPC 8 full level

A61K 31/7105 (2006.01); C12Q 1/48 (2006.01)

CPC (source: EP KR US)

A61K 31/7105 (2013.01 - EP KR US); A61K 38/43 (2013.01 - KR); A61P 1/00 (2017.12 - EP); A61P 1/04 (2017.12 - EP); A61P 1/16 (2017.12 - EP); A61P 1/18 (2017.12 - EP); A61P 3/00 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 7/00 (2017.12 - EP); A61P 7/02 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 9/04 (2017.12 - EP); A61P 9/06 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 11/00 (2017.12 - EP); A61P 13/08 (2017.12 - EP); A61P 13/10 (2017.12 - EP); A61P 13/12 (2017.12 - EP); A61P 15/10 (2017.12 - EP); A61P 17/00 (2017.12 - EP); A61P 19/02 (2017.12 - EP); A61P 19/04 (2017.12 - EP); A61P 21/00 (2017.12 - EP); A61P 21/04 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/02 (2017.12 - EP); A61P 25/16 (2017.12 - EP); A61P 25/18 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 27/02 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 31/14 (2017.12 - EP); A61P 31/20 (2017.12 - EP); A61P 37/02 (2017.12 - EP); A61P 37/08 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C12N 9/13 (2013.01 - EP KR US); C12N 15/1137 (2013.01 - EP KR US); C12Q 1/48 (2013.01 - EP KR US); C12Q 1/485 (2013.01 - EP KR US); G01N 33/5023 (2013.01 - KR US); C12N 2310/14 (2013.01 - EP KR US); G01N 2333/91194 (2013.01 - EP KR US); Y10T 436/143333 (2015.01 - EP US)

Citation (applicant)

  • PETER H. SEEBERGERDANIEL B. WERZ, NATURE, vol. 446, 2007, pages 1046 - 1051
  • ALTSCHUL ET AL., PROC. NATL. ACAD. SCI. USA, vol. 87, 1990, pages 2264 - 8
  • KARLINALTSCHUL, PROC. NATL. ACAD. SCI. USA, vol. 90, 1993, pages 5873 - 7
  • "Hirashima and Inoue, Shin Seikagaku Jikken Koza 2 (New Courses in Experimental Biochemistry 2), Kakusan (Nucleic Acids) IV", 1993, article "Idenshi no Fukusei to Hatsugen (Gene replication and expression", pages: 319 - 347
  • "Gene Bank", Database accession no. NM_029935
  • KOIZUMI, MOTSUKA, E., TANPAKUSHITSU KAKUSAN KOSO (PROTEIN, NUCLEIC ACID, AND ENZYME, vol. 35, 1990, pages 2191
  • KOIZUMI, M. ET AL., FEBS LETT., vol. 239, 1988, pages 285
  • KOIZUMI, M., NUCL ACIDS RES., vol. 17, 1989, pages 7059
  • BUZAYAN, J.M., NATURE, vol. 323, 1986, pages 349
  • KIKUCHI, Y.SASAKI, N., NUCL ACIDS RES., vol. 19, 1991, pages 6751
  • KIKUCHI, Y., KAGAKU TO SEIBUTSU (CHEMISTRY AND BIOLOGY, vol. 30, 1992, pages 112
  • FIRE, A., NATURE, vol. 391, 1998, pages 806 - 811
  • OCHIYA, T. ET AL., NAT. MED., vol. 5, 1999, pages 707 - 710
  • OCHIYA, T. ET AL., CURR. GENE THER., vol. 1, 2001, pages 31 - 52
  • NATURE, vol. 391, no. 6670, 26 February 1998 (1998-02-26), pages 908 - 11
  • MANDON, E.C.MILLA, M.E.KEMPNER, E.HIRSCHBERG, C.B., PROC. NATL. ACAD. SCI. USA, vol. 91, 1994, pages 10707 - 10711
  • OZERAN, J.D.WESLEY, J.SCHWARZ, N.B., BIOCHEMISTRY, vol. 35, 1996, pages 3695 - 3703
  • ANAL BIOCHEM., vol. 256, no. 2, 15 February 1998 (1998-02-15), pages 229 - 37
  • LONGHU LI, CIRCULATION, vol. 113, 2006, pages 535 - 543
  • XIAOMING YI, AM J PHYSIOL HEART CIRC PHYSIOL, vol. 290, 2006, pages H1098 - H1102
  • KANG YJ, J BIOL CHEM., vol. 275, no. 18, 5 May 2000 (2000-05-05), pages 13690 - 8
  • NOZAKI N, CIRCULATION, vol. 110, 2004, pages 2869 - 2874
  • FISHER PW, CIRCULATION, vol. 111, 2005, pages 1601 - 1610
  • JUGDUTT BI, CIRCULATION, vol. 108, 2003, pages 1395 - 1403
  • "Gene Bank", Database accession no. NM_016803
  • SASAKI N, J INFLAMM., vol. 2, 2005, pages 13
  • PUCILOWSKA JB ET AL., AM J PHYSIOL GASTROENTEROL LIVER PHYSIOL, vol. 279, 2000, pages G653 - G659
  • KIHARA M., GUT, vol. 52, 2003, pages 713 - 9
  • KARLINSKY JB ET AL., AM REV RESPIR DIS, vol. 117, 1978, pages 1109 - 1133
  • OTTO-VERBEME CJ ET AL.: "Protective effect of pulmonary surfactant on elastase-induced emphysema in mice", EUR RESPIR J, vol. 5, 1992, pages 1223 - 1230
  • JANOFF A ET AL.: "revention of elastase-induced experimental emphysema by oral administration of a synthetic elastase inhibitor", AM REV RESPIR DIS, vol. 121, 1980, pages 1025 - 1029
  • CHRISTENSEN TG ET AL.: "Irreversible bronchial goblet cell metaplasia in hamsters with elastase-induced panacinar emphysema", J CLIN INVEST, vol. 59, 1977, pages 397 - 404
  • LUCEY EC ET AL.: "Remodeling of alveolar walls after elastase treatment of hamsters: results of elastin and collagen mRNA in situ hybridization", AM J RESPIR CRIT CARE MED, vol. 158, 1998, pages 555 - 564
  • SNIDER GLLUCEY ECSTONE PJ: "Animal models of emphysema", AM REV RESPIR DIS, vol. 133, 1986, pages 149 - 169
  • JOHNSON KH ET AL., N ENG J MED, vol. 321, 1989, pages 513
  • RHODES CJ, SCIENCE, vol. 307, 2005, pages 380
  • HAAN MN, NAT CLIN PRACT NEUROL, vol. 3, 2006, pages 159
  • REMUZZI G ET AL., J CLIN INVEST, vol. 116, 2006, pages 1802
  • SERGIO A ET AL., HYPERTENSION, vol. 38, 2001, pages 635
  • WEINER DE, JASN, vol. 15, 2004, pages 1307
  • ANAVEKAR NS, N ENG J MED, vol. 351, 2004, pages 1285
  • TONELLI M, BMJ, vol. 332, 2006, pages 1426
  • KHWAJA A ET AL., KIDNEY INTERNATIONAL
  • AMERICAN JOURNAL OF PATHOLOGY, vol. 163, no. 4, 2003, pages 1261 - 1273
  • FIEDLANDER M., J CLIN INVEST, vol. 117, 2007, pages 539 - 586
  • HARADA T ET AL., GENES AND DEV, vol. 21, 2007, pages 367 - 378
  • BRITTIS PA ET AL., SCIENCE, vol. 255, 1992, pages 733
  • FISCHER AJ, NATURE NEUROSCIENCE, vol. 4, 2001, pages 247
  • OOTO S ET AL., PNAS, vol. 101, 2004, pages 13645
  • BATALLER R ET AL., J CLIN INVEST, vol. 115, 2005, pages 209
  • DAI K ET AL., WORLD J GACTROENTEROL, vol. 31, 2005, pages 4822 - 4826
  • HILLEBRANDT S ET AL., NATURE GENETICS, vol. 37, 2005, pages 835 - 843
  • AMENDE ET AL., JOURNAL OF NEUROENGINEERING AND REHABILITATION, vol. 2, no. 20, 2005, pages 1 - 13
  • WYNN TA, J. CLIN. INVEST., vol. 117, 2007, pages 524 - 529

Citation (search report)

  • [E] EP 2172226 A1 20100407 - STELIC INSTITUTE REGENERATIVE MEDICINE [JP], et al & WO 2009004995 A1 20090108 - STELIC INSTITUTE REGENERATIVE MEDICINE [JP], et al
  • [AP] EP 1941906 A1 20080709 - STELIC INSTITUTE REGENERATIVE MEDICINE [JP] & WO 2007049424 A1 20070503 - STELIC INSTITUTE REGENERATIVE MEDICINE [JP], et al
  • [A] WO 03098184 A2 20031127 - UNIV CALIFORNIA [US], et al
  • [A] HEMMERICH S ET AL: "Strategies for drug discovery by targeting sulfation pathways", DRUG DISCOVERY TODAY, ELSEVIER, RAHWAY, NJ, US, vol. 9, no. 22, 15 November 2004 (2004-11-15), pages 967 - 975, XP004633808, ISSN: 1359-6446, DOI: 10.1016/S1359-6446(04)03261-1
  • [A] JOCELYN R. GRUNWELL ET AL: "Carbohydrate Sulfotransferases of the GalNAc/Gal/GlcNAc6ST Family +", BIOCHEMISTRY, vol. 41, no. 44, 1 November 2002 (2002-11-01), pages 13117 - 13126, XP055007798, ISSN: 0006-2960, DOI: 10.1021/bi020507h
  • [A] HABUCHI O: "Diversity and functions of glycosaminoglycan sulfotransferases", BIOCHIMICA ET BIOPHYSICA ACTA - GENERAL SUBJECTS, ELSEVIER SCIENCE PUBLISHERS, NL, vol. 1474, no. 2, 6 April 2000 (2000-04-06), pages 115 - 127, XP004276547, ISSN: 0304-4165, DOI: 10.1016/S0304-4165(00)00016-7
  • [T] KENJI SUZUKI ET AL: "Pivotal Role of Carbohydrate Sulfotransferase 15 in Fibrosis and Mucosal Healing in Mouse Colitis", PLOS ONE, vol. 11, no. 7, 13 July 2016 (2016-07-13), pages e0158967, XP055470858, DOI: 10.1371/journal.pone.0158967
  • [T] KENJI SUZUKI ET AL: "New endoscopic approach of anti-fibrotic therapy for inflammatory bowel disease", ANNALS OF TRANSLATIONAL MEDICINE, vol. 5, no. 8, 1 April 2017 (2017-04-01), pages 191 - 191, XP055470898, ISSN: 2305-5839, DOI: 10.21037/atm.2017.03.65

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

DOCDB simple family (publication)

EP 2238987 A1 20101013; EP 2238987 A4 20111102; CN 101965196 A 20110202; CN 103656644 A 20140326; EP 3045178 A1 20160720; EP 3360556 A1 20180815; EP 3360556 B1 20200408; EP 3673910 A1 20200701; EP 3673910 B1 20231122; JP 2011037847 A 20110224; JP 2011162558 A 20110825; JP 4585611 B2 20101124; JP 4751956 B2 20110817; JP 5481426 B2 20140423; JP WO2009084232 A1 20110519; KR 101926292 B1 20181206; KR 102244872 B1 20210427; KR 20100111282 A 20101014; KR 20160007671 A 20160120; KR 20160103554 A 20160901; KR 20170100064 A 20170901; KR 20180132162 A 20181211; KR 20190143485 A 20191230; SG 10201402793P A 20141030; SG 10202001748V A 20200429; US 2011027248 A1 20110203; US 2014128452 A1 20140508; US 2015290238 A1 20151015; US 2017067058 A1 20170309; US 2019330637 A1 20191031; US 2022340910 A1 20221027; WO 2009084232 A1 20090709

DOCDB simple family (application)

EP 08866254 A 20081226; CN 200880127570 A 20081226; CN 201310495268 A 20081226; EP 15194114 A 20081226; EP 18151424 A 20081226; EP 20151386 A 20081226; JP 2008004025 W 20081226; JP 2009547912 A 20081226; JP 2010173610 A 20100802; JP 2011110047 A 20110517; KR 20107016694 A 20081226; KR 20157037089 A 20081226; KR 20167022756 A 20081226; KR 20177023558 A 20081226; KR 20187034630 A 20081226; KR 20197037818 A 20081226; SG 10201402793P A 20081226; SG 10202001748V A 20081226; US 201314075919 A 20131108; US 201514704333 A 20150505; US 201615216231 A 20160721; US 201916237875 A 20190102; US 202217805290 A 20220603; US 80996908 A 20081226